Copyright
©The Author(s) 2016.
World J Gastroenterol. Jun 14, 2016; 22(22): 5267-5275
Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5267
Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5267
Table 3 Medical treatment, hospitalizations and surgery in patients with inflammatory bowel disease n (%)
| UC (n = 508) | CD (n = 196) | P value | |
| Corticosteroids | 297 (58) | 133 (68) | < 0.05 |
| Mesalazine (oral, local or both) | 497 (98) | 133 (68) | < 0.01 |
| Immunosupressive agents | 166 (33) | 132 (67) | < 0.01 |
| Ciclosporine | 7 (1) | 2 (1) | |
| Biologic therapy | 34 (7) | 67 (34) | < 0.01 |
| Surgery | 27 (5) | 75 (38) | < 0.01 |
| Intestinal resection | 27 (5) | 50 (25) | < 0.01 |
| Hospitalizations | 176 (35) | 108 (55) | < 0.01 |
| 1 | 113 (64) | 50 (46.3) | < 0.01 |
| 2-3 | 45 (26) | 35 (32.3) | |
| ≥ 4 | 18 (10) | 23 (21.3) | < 0.011 |
- Citation: Simian D, Fluxá D, Flores L, Lubascher J, Ibáñez P, Figueroa C, Kronberg U, Acuña R, Moreno M, Quera R. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients. World J Gastroenterol 2016; 22(22): 5267-5275
- URL: https://www.wjgnet.com/1007-9327/full/v22/i22/5267.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i22.5267